ZA200709872B - use of azithromycin for the production of a medicament for treatment of ocular infections - Google Patents

use of azithromycin for the production of a medicament for treatment of ocular infections

Info

Publication number
ZA200709872B
ZA200709872B ZA200709872A ZA200709872A ZA200709872B ZA 200709872 B ZA200709872 B ZA 200709872B ZA 200709872 A ZA200709872 A ZA 200709872A ZA 200709872 A ZA200709872 A ZA 200709872A ZA 200709872 B ZA200709872 B ZA 200709872B
Authority
ZA
South Africa
Prior art keywords
azithromycin
medicament
treatment
production
ocular infections
Prior art date
Application number
ZA200709872A
Other languages
English (en)
Inventor
Luyckx Jacques
Goldschmidt Pablo
Pilotaz Frederic
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35445697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200709872(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thea Lab filed Critical Thea Lab
Publication of ZA200709872B publication Critical patent/ZA200709872B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200709872A 2005-04-22 2007-11-15 use of azithromycin for the production of a medicament for treatment of ocular infections ZA200709872B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504069A FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires

Publications (1)

Publication Number Publication Date
ZA200709872B true ZA200709872B (en) 2008-09-25

Family

ID=35445697

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200709872A ZA200709872B (en) 2005-04-22 2007-11-15 use of azithromycin for the production of a medicament for treatment of ocular infections

Country Status (25)

Country Link
US (2) US20060252711A1 (fr)
EP (1) EP1877066A1 (fr)
JP (1) JP2008536908A (fr)
KR (1) KR20080008377A (fr)
CN (1) CN101163486B (fr)
AR (1) AR053591A1 (fr)
AU (1) AU2006238595A1 (fr)
BR (1) BRPI0608375A2 (fr)
CA (1) CA2603833A1 (fr)
EA (1) EA200702295A1 (fr)
FR (1) FR2884716B1 (fr)
HK (1) HK1119064A1 (fr)
IL (1) IL186092A (fr)
JO (1) JO3448B1 (fr)
MA (1) MA29467B1 (fr)
MX (1) MX2007013054A (fr)
MY (1) MY169533A (fr)
NO (1) NO20075943L (fr)
PE (1) PE20070157A1 (fr)
SG (1) SG164382A1 (fr)
TN (1) TNSN07370A1 (fr)
TW (1) TWI430799B (fr)
UA (1) UA94708C2 (fr)
WO (1) WO2006111844A1 (fr)
ZA (1) ZA200709872B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098219A1 (fr) 2008-03-05 2009-09-09 PARI Pharma GmbH Compositions de macrolide ayant un goût et une stabilité améliorés
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Smt有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100489759B1 (ko) * 1996-12-09 2005-05-16 바슈 앤드 롬 인코포레이티드 일회용 가요성 컨테이너
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
PT925789E (pt) * 1997-12-02 2004-10-29 Pfizer Prod Inc Es oculares utilizacao de azitromicina no tratamento topico de infecco
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Also Published As

Publication number Publication date
IL186092A (en) 2016-05-31
KR20080008377A (ko) 2008-01-23
FR2884716B1 (fr) 2009-08-21
CN101163486B (zh) 2011-11-30
MX2007013054A (es) 2008-01-14
WO2006111844A1 (fr) 2006-10-26
MA29467B1 (fr) 2008-05-02
HK1119064A1 (en) 2009-02-27
TWI430799B (zh) 2014-03-21
SG164382A1 (en) 2010-09-29
UA94708C2 (ru) 2011-06-10
IL186092A0 (en) 2008-01-20
EA200702295A1 (ru) 2008-04-28
AR053591A1 (es) 2007-05-09
BRPI0608375A2 (pt) 2010-08-31
TW200716142A (en) 2007-05-01
PE20070157A1 (es) 2007-03-09
CA2603833A1 (fr) 2006-10-26
TNSN07370A1 (fr) 2009-03-17
JO3448B1 (ar) 2020-07-05
NO20075943L (no) 2008-01-15
US20100069315A1 (en) 2010-03-18
FR2884716A1 (fr) 2006-10-27
CN101163486A (zh) 2008-04-16
AU2006238595A1 (en) 2006-10-26
EP1877066A1 (fr) 2008-01-16
US20060252711A1 (en) 2006-11-09
JP2008536908A (ja) 2008-09-11
MY169533A (en) 2019-04-22

Similar Documents

Publication Publication Date Title
HK1221956A1 (zh) 用於治療感染的鹵代類苯酞化硼
ZA200808178B (en) Imidazolothiazole compounds for the treatment of disease
IL187904A (en) Use of quinoline derivatives for the preparation of bacterial preparations for the treatment of bacteria caused by bacteria
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
EP1982660A4 (fr) Endoscope de traitement
IL185250A0 (en) Microimplants for ocular administration
ZA200805716B (en) Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
HK1137990A1 (en) Thienyl-containing glycopyranosyl derivatives as antidiabetics
PL2056863T3 (pl) Leczenie chorób oczu
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
EP1894588A4 (fr) Aiguille de traitement medical
PT2056804E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
EP1862153A4 (fr) Canule ophtalmique
GB0523961D0 (en) The treatment of ophthalmic diseases
GB0611240D0 (en) The treatment of increased sebum production
GB0611241D0 (en) The treatment of increased sebum production
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
HK1119064A1 (en) Use of azithromycin for the production of a medicament for treatment of ocular infections
GB0523964D0 (en) The treatment of ophthalmic diseases
PL1927353T3 (pl) Środek leczniczy na dolegliwości rogówki
GB0602857D0 (en) The treatment of sialorrhoea
GB0601091D0 (en) The Treatment Of Ocular Conditions
GB0523962D0 (en) The treatment of ophthalmic diseases
GB0523965D0 (en) The treatment of ophthalmic diseases
AU2005902412A0 (en) Medicinal treatment